A Viewpoint Commentary: Buffalo as a New Model for Long COVID-19 Study and for Recovering the SARS CoV-2 Polyclonal Neutralizing Antibody, Using an Online Affinity Column Adsorption Technology, for Therapeutic Interventional Modality in Humans: A New Mult
{"title":"A Viewpoint Commentary: Buffalo as a New Model for Long COVID-19 Study and for Recovering the SARS CoV-2 Polyclonal Neutralizing Antibody, Using an Online Affinity Column Adsorption Technology, for Therapeutic Interventional Modality in Humans: A New Mult","authors":"J. Seghatchian","doi":"10.6000/1927-520x.2021.10.07","DOIUrl":null,"url":null,"abstract":"Since WHO mentions the pandemic nature of Covid-19 infection, we are witnessing almost 100 million cases and almost over 2 million deaths due to SARS-CoV-2 infection, causing enormous economic devastation on a global scale. Today, when it comes to tackling the immunity against this deadly virus, all the global scientific community are coming together, persuing with rigor all research and development strategies into the identification of the genetic variations of CoV-2; host response to virus variants; and antivirals and vaccines immunotherapy, where the use of Artificial Intelligence [AI] tools in large data and pattern analyses proved to be of enormous help that we could not do without [1].","PeriodicalId":36721,"journal":{"name":"Journal of Buffalo Science","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Buffalo Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6000/1927-520x.2021.10.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Veterinary","Score":null,"Total":0}
引用次数: 0
Abstract
Since WHO mentions the pandemic nature of Covid-19 infection, we are witnessing almost 100 million cases and almost over 2 million deaths due to SARS-CoV-2 infection, causing enormous economic devastation on a global scale. Today, when it comes to tackling the immunity against this deadly virus, all the global scientific community are coming together, persuing with rigor all research and development strategies into the identification of the genetic variations of CoV-2; host response to virus variants; and antivirals and vaccines immunotherapy, where the use of Artificial Intelligence [AI] tools in large data and pattern analyses proved to be of enormous help that we could not do without [1].